| Mustafa Faisal Mustafa Douglas, MD | |
|
5700 E Highway 90, Sierra Vista, AZ 85635-9110 | |
| (520) 263-3190 | |
| Not Available |
| Full Name | Mustafa Faisal Mustafa Douglas |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 5700 E Highway 90, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164032447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R78390 (Arizona) | Secondary |
| 208M00000X | Hospitalist | A185288 (California) | Primary |
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
A worldwide health problem, tuberculosis kills more people than any other bacterial infection. The World Health Organization estimates that two billion people are infected with TB, and that two million people die each year from the disease.
Pharmasset, Inc. announced today that screening has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C.
NPR's health blog "Shots" interviewed Laith Abu-Raddad of the Weill Cornell Medical College in Qatar, co-author of a recent study published in PLoS Medicine that showed "more than five percent of men who have sex with men are infected by HIV in" the Middle East and North Africa (MENA), about "the challenges of researching such a taboo topic."
A new study published in the American Journal of Hypertension finds evidence that the average daily sodium intake of most Americans is actually associated with better health outcomes than intake levels currently recommended by the CDC and major health departments, which are now being viewed by many in the scientific community as excessively and unrealistically low.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mustafa Faisal Mustafa Douglas, MD 289 S Highway 92 Apt 1201, Sierra Vista, AZ 85635-3679 Ph: (312) 978-0764 | Mustafa Faisal Mustafa Douglas, MD 5700 E Highway 90, Sierra Vista, AZ 85635-9110 Ph: (520) 263-3190 |
News Archive
A worldwide health problem, tuberculosis kills more people than any other bacterial infection. The World Health Organization estimates that two billion people are infected with TB, and that two million people die each year from the disease.
Pharmasset, Inc. announced today that screening has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C.
NPR's health blog "Shots" interviewed Laith Abu-Raddad of the Weill Cornell Medical College in Qatar, co-author of a recent study published in PLoS Medicine that showed "more than five percent of men who have sex with men are infected by HIV in" the Middle East and North Africa (MENA), about "the challenges of researching such a taboo topic."
A new study published in the American Journal of Hypertension finds evidence that the average daily sodium intake of most Americans is actually associated with better health outcomes than intake levels currently recommended by the CDC and major health departments, which are now being viewed by many in the scientific community as excessively and unrealistically low.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
› Verified 8 days ago